Denmark· DK-28103530303
Lactulose "Orifarm"
A lactulose product containing lactulose, registered in Denmark by Orifarm Generics A/S. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Lactulose is registered in 16 of 19 countries.
Countries holding a registration under ATC A06AD11 (lactulose), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Lactulose · ATC A06AD11
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Lactulose
- Manufacturer
- Orifarm Generics A/S
- Country
- Denmark (DK)
- ATC code
- A06AD11
- ATC class
- Lactulose
- Defined daily dose
- 12.5 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103530303
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
657 interactions on record for lactulose.
Graded by severity as the source publishes them — 263 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lactulose · interactions on record
657 records
- 263 moderate
- 18 minor
- 376 info
Most severe, free to view
- CisaprideA03FA02moderate
- OndansetronA04AA01moderate
- GranisetronA04AA02moderate
- DolasetronA04AA04moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A06AD11
Lactulose, as other registers publish it.
- NetherlandsAlbert Heijn Laxeerdrank Lactulose 667 mg/ml, stroopHealthypharm B.V.
- GermanyBifiteralCooper Consumer Health Deutschland Gmbh
- United KingdomBifiteral 10g oral powder sachetsImported (Germany)
- BelgiumBifiteral 66.7 g/100 mlCooper Consumer Health
- GermanyBifiteral Mit PflaumenaromaCooper Consumer Health B.V.
- GermanyBifiteral Mit PflaumenaromaViatris Healthcare Gmbh
- IrelandBrillphalac 3.335 g/5 ml oral solutionBrillpharma (Ireland) Limited
- United StatesConstuloseActavis Pharma, Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8ce0481d-fd2b-44dd-b8cc-e10dfef9b601 GET /v1/drugs/8ce0481d-fd2b-44dd-b8cc-e10dfef9b601?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "oral opløsning",
"source": "dkma",
"strength": "667 mg/ml",
"auth_role": "DKMA",
"dk_drugid": "28103530303",
"substance": "Lactulose",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "38462"
}See everything about lactulose.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.